Bispecific Antibody Provides Durable Remission in Myeloma ...Middle East

Medscape - News
REGN5459, designed to deplete plasma cells while mitigating the cytokine release syndrome, demonstrated deep and durable clinical responses in heavily pretreated relapsed/refractory myeloma. Medscape Medical News

Hence then, the article about bispecific antibody provides durable remission in myeloma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bispecific Antibody Provides Durable Remission in Myeloma )

Apple Storegoogle play

Last updated :

Also on site :



Latest News